Vrisha Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Navi Mumbai, Maharashtra, India, established in 2005.
2005 Navi Mumbai, Maharashtra, India Active
Last Updated:
About Vrisha Pharmaceuticals Private Limited

Vrisha Pharmaceuticals Private Limited, a active private limited company, was established on 18 October 2005 in Navi Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U52310MH2005PTC156801. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Formerly known as Vrisha Pharmaceticals Private Limited. It upholds a compliant status. Its leadership includes Jagdish Madhukar Chaudhari (Additional Director), Sajid Syed Asfi (Director), Rajendra Anant Apandkar (Director). Past directors included Jagdish Madhukar Chaudhari, Sajid Syed Asfi, Dada Shankar Yadav. It holds ₹2.96 Cr open charges and ₹3.67 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No.1, Shri Durga Apartment, First Floor,Plot No.186,Sector-10,Sanpad, A,, Navi Mumbai, Maharashtra, 400705.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U52310MH2005PTC156801

  • Registration Number

    156801

  • Incorporation Date

    18 October 2005

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 20 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.96 Cr
  • Satisfied Charges ₹ 3.67 Cr
  • Revenue Growth **** 497.14%
  • Profit Growth **** 79.36%
  • Ebitda **** 195.65%
  • Net Worth -3.58%
  • Total Assets -18.81%
Company report

Vrisha Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Vrisha Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Vrisha Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Jagdish Madhukar Chaudhari Additional Director 17 Dec 2021 Current
Sajid Syed Asfi Director 20 May 2018 Current
Rajendra Anant Apandkar Director 13 Dec 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 03 Jun 2019 Past
Pramod Abcsdd Additional Director 28 Sep 2018 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Director 04 Nov 2011 Past
Pramod Abcsdd Director 02 Nov 2015 Past
Pramod Abcsdd Additional Director 28 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vrisha Pharmaceuticals.

Vrisha Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 497.14% increase. The company also saw a substantial improvement in profitability, with a 79.36% increase in profit. The company's net worth dipped by a decrease of 3.58%.

Vrisha Pharmaceuticals revenue growth over time
Vrisha Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
497.14%
*******
*******
*******
*******
Revenue from Operations
*******
496.14%
*******
*******
*******
*******
Total Assets
*******
-18.81%
*******
*******
*******
*******
Profit or Loss
*******
79.36%
*******
*******
*******
*******
Net Worth
*******
-3.58%
*******
*******
*******
*******
EBITDA
*******
195.65%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vrisha Pharmaceuticals?

Unlock access to Vrisha Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹29,550,000.00

Satisfied Charges

₹36,700,000.00

Charges Breakdown by Lending Institutions
  • Others : 2.01 Cr
  • Axis Bank Limited : 0.95 Cr
Latest Charge Details
Date Lender Amount Status
22 Jul 2016 Others ₹2.01 Cr Open
21 Feb 2011 Axis Bank Limited ₹9.50 M Open
23 Sep 2013 Icici Bank Limited ₹1.77 Cr Satisfied
16 May 2012 First Blue Home Finance Limited ₹4.00 M Satisfied
22 Feb 2011 Standard Chartered Bank ₹1.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Vrisha Pharmaceuticals?

Unlock and access historical data on people associated with Vrisha Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vrisha Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vrisha Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vrisha Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Vrisha Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Vrisha Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Jagdish Madhukar Chaudhari was appointed as a Additional Director was appointed as a Additional Director on 17 Dec 2021 & has been associated with this company since 4 years 1 month . was recorded as a recent event.

  • Director Appointment

    The activity Sajid Syed Asfi was appointed as a Director was appointed as a Director on 20 May 2018 & has been associated with this company since 7 years 8 months . was completed.

  • Director Appointment

    Progress on Rajendra Anant Apandkar was appointed as a Director was appointed as a Director on 13 Dec 2017 & has been associated with this company since 8 years 2 months . was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 20.05 M with Charge ID 100077245 was registered on 22 Jul 2016. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Vrisha Pharmaceuticals Private Limited?

The CIN of Vrisha Pharmaceuticals Private Limited is U52310MH2005PTC156801.

Where is Vrisha Pharmaceuticals Private Limited headquartered?

Vrisha Pharmaceuticals Private Limited is headquartered at Office No.1, Shri Durga Apartment, First Floor,Plot No.186,Sector-10,Sanpad, A,, Navi Mumbai, Maharashtra, 400705.

When was Vrisha Pharmaceuticals Private Limited incorporated?

Vrisha Pharmaceuticals Private Limited was incorporated on 18 October 2005.

Who are the current directors of Vrisha Pharmaceuticals Private Limited?

The current directors of Vrisha Pharmaceuticals Private Limited are

What is the primary industry of Vrisha Pharmaceuticals Private Limited?

The primary industry of Vrisha Pharmaceuticals Private Limited is Trade.

Is Vrisha Pharmaceuticals Private Limited a listed company?

Vrisha Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Vrisha Pharmaceuticals Private Limited?

The authorized capital of Vrisha Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Vrisha Pharmaceuticals Private Limited?

The compliance status of Vrisha Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available